Funding
Turn ideas into impact
Show Me
Due: January 7, 2027
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
US $1,515,000
Type
Grant
Source
Federal
Opp Number
PAR-25-025
Due: January 7, 2027
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
US $375,000
Type
Grant
Source
Federal
Opp Number
PAR-24-214
Due: January 7, 2027
Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-221
Due: January 7, 2027
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-379
Due: January 7, 2027
Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-310
Due: January 7, 2027
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-069
Due: January 7, 2027
Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-378
Due: January 7, 2027
Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 – Clinical Trials Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-377
Due: January 7, 2027
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-070
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?